17-17793779-CCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_030665.4(RAI1):​c.870_872dupGCA​(p.Gln291dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0212 in 1,356,272 control chromosomes in the GnomAD database, including 42 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q291Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.033 ( 26 hom., cov: 0)
Exomes 𝑓: 0.020 ( 16 hom. )

Consequence

RAI1
NM_030665.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.36

Publications

8 publications found
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]
RAI1 Gene-Disease associations (from GenCC):
  • Smith-Magenis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Potocki-Lupski syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_030665.4
BP6
Variant 17-17793779-C-CCAG is Benign according to our data. Variant chr17-17793779-C-CCAG is described in ClinVar as Benign. ClinVar VariationId is 130086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAI1NM_030665.4 linkc.870_872dupGCA p.Gln291dup disruptive_inframe_insertion Exon 3 of 6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkc.870_872dupGCA p.Gln291dup disruptive_inframe_insertion Exon 3 of 6 1 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1
RAI1ENST00000395774.1 linkc.870_872dupGCA p.Gln291dup disruptive_inframe_insertion Exon 2 of 2 2 ENSP00000379120.1 A8MXE8

Frequencies

GnomAD3 genomes
AF:
0.0330
AC:
2599
AN:
78794
Hom.:
27
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0351
Gnomad ASJ
AF:
0.0300
Gnomad EAS
AF:
0.00533
Gnomad SAS
AF:
0.144
Gnomad FIN
AF:
0.0307
Gnomad MID
AF:
0.0281
Gnomad NFE
AF:
0.0374
Gnomad OTH
AF:
0.0282
GnomAD4 exome
AF:
0.0205
AC:
26172
AN:
1277388
Hom.:
16
Cov.:
38
AF XY:
0.0213
AC XY:
13483
AN XY:
631784
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0140
AC:
399
AN:
28582
American (AMR)
AF:
0.0184
AC:
581
AN:
31646
Ashkenazi Jewish (ASJ)
AF:
0.0165
AC:
386
AN:
23362
East Asian (EAS)
AF:
0.00177
AC:
33
AN:
18624
South Asian (SAS)
AF:
0.0408
AC:
2271
AN:
55660
European-Finnish (FIN)
AF:
0.0188
AC:
866
AN:
46154
Middle Eastern (MID)
AF:
0.0292
AC:
142
AN:
4856
European-Non Finnish (NFE)
AF:
0.0202
AC:
20540
AN:
1016610
Other (OTH)
AF:
0.0184
AC:
954
AN:
51894
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.389
Heterozygous variant carriers
0
1443
2886
4328
5771
7214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0329
AC:
2598
AN:
78884
Hom.:
26
Cov.:
0
AF XY:
0.0344
AC XY:
1289
AN XY:
37498
show subpopulations
African (AFR)
AF:
0.0240
AC:
571
AN:
23824
American (AMR)
AF:
0.0351
AC:
206
AN:
5870
Ashkenazi Jewish (ASJ)
AF:
0.0300
AC:
59
AN:
1966
East Asian (EAS)
AF:
0.00535
AC:
4
AN:
748
South Asian (SAS)
AF:
0.145
AC:
118
AN:
814
European-Finnish (FIN)
AF:
0.0307
AC:
186
AN:
6064
Middle Eastern (MID)
AF:
0.0301
AC:
5
AN:
166
European-Non Finnish (NFE)
AF:
0.0373
AC:
1418
AN:
37972
Other (OTH)
AF:
0.0287
AC:
31
AN:
1080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
110
219
329
438
548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0138
Hom.:
2

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Oct 16, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 30, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 06, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RAI1: BS1, BS2 -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 08, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 18, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.4
Mutation Taster
=83/17
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371983878; hg19: chr17-17697093; COSMIC: COSV104555111; COSMIC: COSV104555111; API